Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
2,409
-214
-8% -$20.3K 0.07% 92
2026
Q1
$238K Sell
2,623
-521
-17% -$51.5K 0.08% 85
2025
Q4
$353K Sell
3,144
-893
-22% -$105K 0.13% 64
2025
Q3
$512K Sell
4,037
-211
-5% -$29.3K 0.18% 47
2025
Q2
$618K Sell
4,248
-281
-6% -$42.3K 0.25% 34
2025
Q1
$699K Sell
4,529
-374
-8% -$55K 0.31% 28
2024
Q4
$687K Sell
4,903
-414
-8% -$58.8K 0.33% 27
2024
Q3
$713K Buy
5,317
+135
+3% +$17.1K 0.34% 24
2024
Q2
$614K Buy
5,182
+159
+3% +$19.4K 0.33% 30
2024
Q1
$617K Buy
5,023
+384
+8% +$46.6K 0.33% 28
2023
Q4
$553K Buy
4,639
+222
+5% +$26.3K 0.39% 23
2023
Q3
$509K Sell
4,417
-1,820
-29% -$219K 0.4% 21
2023
Q2
$698K Buy
6,237
+131
+2% +$14.3K 0.54% 23
2023
Q1
$700K Buy
6,106
+235
+4% +$26.7K 0.53% 21
2022
Q4
$678K Buy
5,871
+204
+4% +$23.9K 0.55% 23
2022
Q3
$636K Buy
5,667
+111
+2% +$13.8K 0.53% 26
2022
Q2
$633K Buy
5,556
+232
+4% +$29.1K 0.64% 27
2022
Q1
$727K Sell
5,324
-10
-0.2% -$1.23K 0.65% 26
2021
Q4
$728K Buy
+5,334
New +$659K 0.69% 25

Other funds holding PAYX

Rise Advisors's PAYX Position: Q2 2026 in Review

Rise Advisors reduced its Paychex (PAYX) stake by 8.2% in Q2 2026, selling an estimated $20.3K and leaving 2,409 shares worth $237K. The position accounts for 0.07% of the portfolio, ranked #92.

Rise Advisors first reported a position in PAYX in Q4 2021 and has held it in 19 quarters since. The position peaked at $728K in Q4 2021. 1,526 funds tracked by Wall St. Rank hold PAYX as of Q2 2026.

  • Rise Advisors held 2,409 shares of Paychex worth $237K as of Q2 2026.
  • Rise Advisors sold 214 Paychex shares in Q2 2026, an estimated $20.3K.
  • Paychex made up 0.07% of Rise Advisors's portfolio in Q2 2026, its #92 holding.
  • Rise Advisors first reported a position in Paychex in Q4 2021 and has held it in 19 quarters since.
  • Rise Advisors's Paychex position peaked at $728K in Q4 2021.
  • 1,526 funds tracked by Wall St. Rank held Paychex as of Q2 2026.

Based on Rise Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.